🔎 Trials Near Me

Home › Ulcerative Colitis › NCT07520461

Microbiome-targeted Diet Therapy in Ulcerative Colitis

Recruiting

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Ability and willingness to provide informed consent
* Age at least 18 years old
* Diagnosis of UC based on clinical and endoscopic criteria
* UC duration of at least 3 months
* Ulcerative Colitis Endoscopic Index of Severity (UCEIS) score ≤4 within 90 days of randomization
* On a stable dose or no existing UC therapies (apart from steroids) for defined periods (as outlined below).

  1. ≥4 weeks if no medication, 5-ASA
  2. ≥8 wk for immunomodulatory therapy
  3. ≥12 wk for biologics
* Ability to comply with study requirements in the opinion of the primary investigator

Exclusion Criteria:

* Moderate or severe UC as defined by UCEIS ≥5
* History of stomach surgery or bowel resection
* Antibiotic use within 3 months
* Anticipated antibiotic exposure during the study period (e.g. perioperative antibiotics)
* Pregnancy or breastfeeding
* History of anaphylactic food allergies
* Intolerance of high dietary fiber content
* Ongoing alcohol or drug abuse
* Habitual vegan diet pattern
* Insufficient freezer space to accommodate meal delivery

About the study

The central objective of this proposal is to test a novel diet capable of meeting the elevated protein requirements in ulcerative colitis (UC), while simultaneously decreasing microbial hydrogen sulfide (H2S) production in the colon with fiber.

What is being tested

Sponsor: University of Minnesota · Participants: 40 · Started: Sep 26, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07520461

Locations in the U.S.

MinnesotaUniversity Of Minnesota, Minneapolis

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.